WallStreetZenWallStreetZen

NASDAQ: TLPH
Talphera Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TLPH

Based on 2 analysts offering 12 month price targets for Talphera Inc

Min Forecast
$3.00+238.98%
Avg Forecast
$3.00+238.98%
Max Forecast
$3.00+238.98%

Should I buy or sell TLPH stock?

Based on 2 analysts offering ratings for Talphera Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TLPH stock forecasts and price targets.

TLPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-05
lockedlocked$00.00+00.00%2026-04-30

1 of 1

Forecast return on equity

Is TLPH forecast to generate an efficient return?

Company
74.49%
Industry
51.93%
Market
175.93%
TLPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TLPH forecast to generate an efficient return on assets?

Company
45.64%
Industry
19.75%
TLPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TLPH earnings per share forecast

What is TLPH's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.25
Avg 2 year Forecast
-$0.28
Avg 3 year Forecast
-$0.17

TLPH revenue forecast

What is TLPH's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$5.7M+569,800%
Avg 3 year Forecast
$14.3M+1,425,100%
TLPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TLPH revenue growth forecast

How is TLPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
2,303.22%
Industry
8.77%
Market
13.98%
TLPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TLPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TLPH vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TLPH$0.89$3.00+238.98%Strong Buy
IXHL$3.67$18.00+390.46%Strong Buy
KALA$2.64N/AN/A
SCYX$4.09N/AN/A
INCR$0.96N/AN/A
View Top Pharmaceutical Stocks

Talphera Stock Forecast FAQ

Is Talphera Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TLPH) stock is to Strong Buy TLPH stock.

Out of 2 analysts, 1 (50%) are recommending TLPH as a Strong Buy, 1 (50%) are recommending TLPH as a Buy, 0 (0%) are recommending TLPH as a Hold, 0 (0%) are recommending TLPH as a Sell, and 0 (0%) are recommending TLPH as a Strong Sell.

If you're new to stock investing, here's how to buy Talphera stock.

What is TLPH's earnings growth forecast for 2026-2028?

(NASDAQ: TLPH) Talphera's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 12.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.71%.

Talphera's earnings in 2026 is -$14,253,000.On average, 4 Wall Street analysts forecast TLPH's earnings for 2026 to be -$12,969,722, with the lowest TLPH earnings forecast at -$12,715,414, and the highest TLPH earnings forecast at -$13,078,711. On average, 5 Wall Street analysts forecast TLPH's earnings for 2027 to be -$14,293,163, with the lowest TLPH earnings forecast at -$14,749,880, and the highest TLPH earnings forecast at -$13,623,658.

In 2028, TLPH is forecast to generate -$8,999,399 in earnings, with the lowest earnings forecast at -$9,663,714 and the highest earnings forecast at -$8,174,195.

What is TLPH's revenue growth forecast for 2026-2028?

(NASDAQ: TLPH) Talphera's forecast annual revenue growth rate of 2,303.22% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.98%.

Talphera's revenue in 2026 is $1,000.On average, 3 Wall Street analysts forecast TLPH's revenue for 2026 to be $0, with the lowest TLPH revenue forecast at $0, and the highest TLPH revenue forecast at $0. On average, 4 Wall Street analysts forecast TLPH's revenue for 2027 to be $295,776,094, with the lowest TLPH revenue forecast at $284,150,573, and the highest TLPH revenue forecast at $304,443,335.

In 2028, TLPH is forecast to generate $739,673,783 in revenue, with the lowest revenue forecast at $376,687,645 and the highest revenue forecast at $1,111,690,460.

What is TLPH's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TLPH) forecast ROA is 45.64%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 19.75%.

What is TLPH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TLPH price target, the average TLPH price target is $3.00, with the highest TLPH stock price forecast at $3.00 and the lowest TLPH stock price forecast at $3.00.

On average, Wall Street analysts predict that Talphera's share price could reach $3.00 by Jun 5, 2027. The average Talphera stock price prediction forecasts a potential upside of 238.98% from the current TLPH share price of $0.89.

What is TLPH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TLPH) Talphera's current Earnings Per Share (EPS) is -$0.28. On average, analysts forecast that TLPH's EPS will be -$0.25 for 2026, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.25. On average, analysts forecast that TLPH's EPS will be -$0.28 for 2027, with the lowest EPS forecast at -$0.28, and the highest EPS forecast at -$0.26. In 2028, TLPH's EPS is forecast to hit -$0.17 (min: -$0.19, max: -$0.16).

What is TLPH's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TLPH) forecast ROE is 74.49%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.